| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |